Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-951-9 | CAS number: 101-54-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Methemoglobinemia was observed in cats after single oral administration of a non-lethal dose (Bayer AG 1957). In rats, the oral LD50 value was determined as 336 mg/kg bw in a GLP and guideline study (Monsanto Co. 1991b). Clinical signs of toxicity included ataxia, nasal, oral and ocular discharge, difficult breathing, and hypoactivity. The most notable internal necropsy observations for animals which died consisted of abnormalities of the digestive tract, urinary bladder, brain, lymph nodes, thymus and adrenal glands. In addition, observations of animals which survived showed also adverse effects on the digestive tract which may represent an irritant effect of the test material.
The acute dermal toxicity of 4-ADPA was very low with an LD50 value of greater than 5000 mg/kg bw in rabbits. The only clinical signs noted in some animals were nasal and ocular discharge and single occurrence of red and/or swollen eyes.
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 336 mg/kg bw
Acute toxicity: via dermal route
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 5 000 mg/kg bw
Additional information
Acute toxicity: oral
The acute oral toxicity of 4-Aminodiphenylamine (4-ADPA) was evaluated in a GLP and Guideline study using Sprague Dawley rats. A variety of adverse clinical signs was noted in treated animals. The most notable clinical signs included piloerection, decreased activity, urine/faecal strains, decreased defecation, reddish/orange coloured urine, breathing abnormalities and dark material around the facial area. The majority of these signs occurred during days 1 to 5. Body weight loss was noted in one female at 350 mg/kg bw dose level. All other surviving animals exhibited body weight gains during the test period. In the animals surviving until necropsy on study day 15, one animal from the 250 mg/kg level exhibited adhesions involving the stomach and surrounding tissues. The most notable internal necropsy observations for animals which died consisted of abnormalities of the digestive tract, urinary bladder, brain, lymph nodes, thymus and adrenal glands. The acute oral LD50 for 4 -ADPA for male rats was calculated to be 370 mg/kg bw. In female rats, the acute oral LD50 of 4-ADPA was calculated to be 300 mg/kg bw. In the sexes combined, the acute oral LD50 of 4 -ADPA was calculated to be 336 mg/kg bw (Monsanto Co. 1991b).
In a previous study which was done with CDR rats an acute oral LD50 of 720 mg/kg bw was calculated for both sexes combined. In this study toxicological signs were seen during the 24 hours after dosing in all groups including ataxia nasal, oral and ocular discharge, hyperpnea, and hypopnea, wet rales, urinary and faecal staining, unthrifty coat, alopecia, hypoactivity, prostration and decreased food consumption. Necropsy observations found were reddening of the stomach and intestinal walls, which may represent an irritant effect of the test material on the gastrointestinal mucosa (Monsanto Co. 1984a).
In an acute oral toxicity study with cats, a single dose of 25 mg 4 -ADPA/ kg bw led to slight and reversible increase in methemoglobin levels in 2 female cats (maximal value of 11% at 3 hours p.a.), whilst Heinz bodies were not increased in comparison to reference values (Bayer AG 1985). The ability to induce methemoglobinemia is supported by results of a former study (Bayer AG 1957), but no quantitative information can be derived from this investigation due to a number of restrictions (e.g. only one cat/dose, determination of methemoglobin only 1 and 2 hours after dosing, no reverence value given). Additionally in this study cyanosis was observed in cats dosed with 25 or 100 mg/kg bw, whilst 10 mg/kg bw were without evident effects.
Acute toxicity: inhalation
There are no valid data available for the acute inhalation toxicity.
Acute toxicity: dermal
The acute dermal toxicity of the test substance 4-ADPA was evaluated with New Zealand White rabbits in a GLP and Guideline study. No mortality was observed in the dose range finding study up to 5000 mg/kg bw. Thus, in the main study five male and five female rabbits were treated with 5000 mg/kg bw test substance for 24 hours, followed by a 14 d observation period. All animals survived throughout the study. Therefore, the dermal LD50 of 4-ADPA in rabbits is greater than 5000 mg/kg bw. Most animals were free of significant signs of systemic toxicity, although some occurrence of nasal discharge were seen as were single occurrence of red and/or swollen eyes, food consumption decrease and ocular discharge. One animal exhibited a swollen left eye and a red nictitating membrane in the same eye during the day of dosing and or the day after dosing (Monsanto Co. 1984b).
Acute toxicity: other routes
There are no data available.
Human information
There are no valid data available.
Justification for classification or non-classification
Based on the findings of the above mentioned GLP and OECD guideline study (Monsant Co. 1991b, LD50 336 mg/kg bw) the test substance 4-ADPA is classified as harmful if swallowed to the classification criteria 67/548/EWG and regulation no. 1272/2008 (GHS).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.